Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIFTY: Fractional Doses of Yellow Fever Vaccine
NCT04059471Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Live Attenuated Vaccines
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of 17D yellow fever vaccine in yellow fever (4 arms), sponsored by University of Oxford. Primary endpoint: Proportion of vaccinees that seroconverts as measured by Plaque Reduction Neutralisation Test (PRNT-50) at 28 days. Started Nov 2019; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT04059471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059471.